Integrating Multidisciplinary Care and Immunotherapy for Durable, Long-Term Outcomes in Non-Melanoma Skin Cancer

Integrating Multidisciplinary Care and Immunotherapy for Durable, Long-Term Outcomes in Non-Melanoma Skin Cancer is organized by Med Learning Group.

Released Date: July 11, 2024
Expiration Date: July 11, 2025

Description:
This enduring program will inform multidisciplinary teams who care for patients with cutaneous squamous cell carcinomas (cSCC) or basal cell carcinoma. This activity incorporates didactic presentation, illustrative animation, and case-based discussion to improve understanding of the rationale for using immune checkpoint inhibition to complement surgery for cSCC; raise awareness of clinical evidence for approved and investigational immunotherapy-based treatment of advanced disease; and address the use of multidisciplinary patient care strategies, including risk assessment, treatment planning, adverse event management, communication, and patient education.

Learning Objectives:
Upon the completion of this program, attendees should be able to:

• Explain the most up-to-date clinical evidence for approved and investigational immunotherapeutic approaches to the treatment of advanced cutaneous squamous cell carcinoma or basal cell carcinoma
• Implement strategies for multidisciplinary care of patients with advanced cutaneous squamous cell carcinoma or basal cell carcinoma, including risk assessment, communication, and patient education